-+ 0.00%
-+ 0.00%
-+ 0.00%

TransCode Therapeutics Advances TTX-MC138 to Phase 2a Trials After Positive Phase 1a Results in Metastatic Disease

Reuters·10/14/2025 12:06:49

Please log in to view news